About
Contact & Profiles
A5036968804
Research Areas
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Asthma and respiratory diseases
- Long-Term Effects of COVID-19
- Dermatology and Skin Diseases
- Vaccine Coverage and Hesitancy
- Allergic Rhinitis and Sensitization
Regeneron (United States)
2021
Background: Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to intranasal corticosteroids and/or antihistamines but carries risk of systemic reactions. Dupilumab blocks the shared receptor component interleukin-4 and interleukin-13, key central drivers type 2 inflammation in multiple diseases. Objective: To evaluate efficacy safety SCIT+dupilumab vs SCIT alone. Methods: This phase 2a,...
10.2147/jaa.s318892
article
EN
cc-by-nc
Journal of Asthma and Allergy
2021-08-01
Coming Soon ...